Cancer
Enzyme-responsive 2-dimensional nanomaterials for targeted breast cancer treatment.
- Journal
- Journal of drug targeting
- Published
- December 28, 2026
- Source
- PubMed / NLM
- Credibility
- 83 / 100
Key takeaway
Researchers are designing microscopic carriers that release medicine directly inside breast tumors, sparing healthy cells. Because Black women face the highest death rates from breast cancer, developing treatments that attack tumors more effectively with fewer harsh side effects is vital for our community.
Why this matters for our communities
Research in cancer helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cancer
February 1, 2027Dual-modal immunoassay for prostate cancer-derived exosomes enabled by a black phosphorus/silver SERS substrate and Yb/Er co-doped NaGdF4 UCL nanoprobes.Read December 18, 2026Factors Associated with Screening Mammography Utilization Among Women Veterans in VA Primary Care.Read December 17, 2026A mechanistic learning framework for breast cancer relapse prediction.Read